ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 170 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $31,527 | -34.7% | 10,651 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $48,250 | -20.7% | 10,651 | 0.0% | 0.00% | -50.0% |
| Q4 2023 | $60,818 | +24.1% | 10,651 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $48,995 | -28.8% | 10,651 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $68,806 | -14.3% | 10,651 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $80,309 | -25.6% | 10,651 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $107,895 | +2.8% | 10,651 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $105,000 | -7.1% | 10,651 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $113,000 | +8.7% | 10,651 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $104,000 | -31.6% | 10,651 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $152,000 | -85.0% | 10,651 | -79.0% | 0.01% | -86.3% |
| Q3 2021 | $1,014,000 | -9.0% | 50,651 | 0.0% | 0.05% | -13.6% |
| Q2 2021 | $1,114,000 | – | 50,651 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |